Gemfibrozil clinical trials cholesterol lowering intervention

Ausgem - ApoGemfibrozil - Apo Gemfibrozil - Apo-Gemfibrozil - SBPA Gemfibrozil - Pilder - Lipur - Lopid R - Lopid - Litarek - Lipox Gemfi - Lipazil - Jezil - Healthsense Gemfibrozil - GenRX Gemfibrozil - GenGemfibrozil - Gen Gemfibrozil - Gen-Gemfibrozil - Gemhexal - Gemfibrozilo Ur - Gemfi 1A Pharma - Decrelip - Trialmin - DBL Gemfibrozil - CI719 - CI 719 - CI-719 - Bolutol - Gemfibrosil - Gemfibrozil

Atrial fibrillation

1 trials  - VA HIT (AF ancillary study)

Cardiovascular prevention

All chronical situations:  3 trials  - VA-HIT - LOCAT - Helsinki (HHS)

All type of patients:  4 trials  - VA-HIT - LOCAT - HHS (Frick)(secondary prev subgroup) - Helsinki (HHS)

Diabetic patients :  2 trials  - VA-HIT (diabetic sub group) - HHS (diabetic sub group)

Patients with LDL elevation and without CHD:  1 trials  - Helsinki (HHS)

Patients with prior MI or with CHD:  3 trials  - VA-HIT - LOCAT - HHS (Frick)(secondary prev subgroup)

Diabetes type 2

Diabetic patients with or withour hypercholesterolemia:  2 trials  - VA-HIT (diabetic sub group) - HHS (diabetic sub group)

Primary prevention:  1 trials  - HHS (diabetic sub group)

Secondary prevention:  1 trials  - VA-HIT (diabetic sub group)

Post myocardial infarction

1 trials  - VA-HIT